Noble Roman's, Inc.
NROM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.08 | 0.06 | 0.05 |
| FCF Yield | 7.58% | 1.95% | 4.91% | 0.01% |
| EV / EBITDA | 14.07 | 25.73 | 66.56 | 26.22 |
| Quality | ||||
| ROIC | 4.57% | 2.51% | 0.23% | 2.63% |
| Gross Margin | 34.36% | 27.39% | 32.81% | 28.06% |
| Cash Conversion Ratio | 1.07 | 1.21 | -2.40 | 0.12 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.98% | 2.16% | 1.58% | 0.15% |
| Free Cash Flow Growth | 154.95% | -63.46% | 92,919.61% | 100.36% |
| Safety | ||||
| Net Debt / EBITDA | 9.62 | 15.46 | 38.88 | 16.12 |
| Interest Coverage | 2.16 | 1.52 | 0.17 | 1.00 |
| Efficiency | ||||
| Inventory Turnover | 2.67 | 2.78 | 2.52 | 2.89 |
| Cash Conversion Cycle | 40.61 | 39.57 | 31.92 | 46.29 |